LKB1 is a DNA damage response protein that regulates cellular sensitivity to PARP inhibitors

Yi-Shu Wang(First Bethune Hospital of Jilin University), Zhixiang Xu(University of Electronic Science and Technology of China), Fengmei Cui(Soochow University), Yong‐Ping Jian(Henan University), Chengshi Quan(Jilin University), Rutao Cui(Zhejiang University), Shuai Wang(Army Medical University), Jianfeng Chen(Sun Yat-sen University), Qinghua Zeng(University of Alabama at Birmingham), Huibo Wang(Jiangsu Cancer Hospital), Jiyong Liang(The University of Texas MD Anderson Cancer Center), Ying-Xian Zhai(First Bethune Hospital of Jilin University), Xiang-Feng Shen(First Bethune Hospital of Jilin University), Yulin Li(Ministry of Education of the People's Republic of China), Jian-Wei Wang(First Bethune Hospital of Jilin University), Wei Hang(Tianjin Huanhu Hospital), Rui-Xun Zhao(University of Alabama at Birmingham), Kaitlin D. Werle(University of Alabama at Birmingham)
Oncotarget
September 29, 2016
Cited by 41


Related Papers